{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T20:38:42Z","timestamp":1769805522841,"version":"3.49.0"},"reference-count":0,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although Depo-Provera is best known as an injectable hormonal contraceptive, the drug also served as a method of menstrual suppression for institutionalized women with intellectual disabilities in the late twentieth-century United States, even after the Food and Drug Administration refused to license it for this purpose. To understand how institutionalized women came to be injected with Depo-Provera in the 1980s, this article investigates the controversy at A School for Me, a Navajo-run institution that came under fire during a 1987 congressional hearing for administering Depo-Provera to its residents. Beyond its utility as a contraceptive, many physicians and institutional administrators saw Depo-Provera as a treatment for menstrual anxiety, a reprieve for care workers, a non-surgical substitute for sterilization, and a delayer of puberty for women with intellectual disabilities. These perceived benefits explain why some physicians and administrators championed routine injections of Depo-Provera in institutional settings, despite public backlash and concerns about the drug\u2019s potential to cause cancer. Framing Depo-Provera as a form of care enabled it to be deployed as a form of control over these women\u2019s menstruation and their bodyminds.<\/jats:p>\n                  <jats:p>Editor's Note: This article received the American Association for the History of Medicine 2025 Shryock Medal, an award for an outstanding, unpublished essay by a single author graduate student on any topic in the history of medicine.<\/jats:p>","DOI":"10.1093\/jhmas\/jraf027","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:56:05Z","timestamp":1764075365000},"source":"Crossref","is-referenced-by-count":0,"title":["These \u201cChildren Won\u2019t Become Women\u201d: Depo-Provera, Intellectual Disability, and the Indian Health Service"],"prefix":"10.1093","author":[{"given":"Emma","family":"Wathen","sequence":"first","affiliation":[{"name":"University of Wisconsin\u2013Madison ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,30]]},"container-title":["Journal of the History of Medicine and Allied Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jhmas\/advance-article-pdf\/doi\/10.1093\/jhmas\/jraf027\/66639366\/jraf027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jhmas\/advance-article-pdf\/doi\/10.1093\/jhmas\/jraf027\/66639366\/jraf027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:09:10Z","timestamp":1769767750000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jhmas\/advance-article\/doi\/10.1093\/jhmas\/jraf027\/8445262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1093\/jhmas\/jraf027","relation":{},"ISSN":["0022-5045","1468-4373"],"issn-type":[{"value":"0022-5045","type":"print"},{"value":"1468-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"article-number":"jraf027"}}